Tocqueville Asset Management L.P. Ionis Pharmaceuticals Inc Transaction History

Tocqueville Asset Management L.P.

$5.99 Billion
Q2 2024

A detailed history of Tocqueville Asset Management L.P. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 225,070 shares of IONS stock, worth $9.19 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

225,070

Previous 159,380 41.22%

Holding current value

$9.19 Million

Previous $6.91 Million 55.25%

% of portfolio

0.18%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$36.45 - $47.7 $2.39 Million - $3.13 Million	65,690 Added 41.22%	225,070 $10.7 Million
Q1 2024 May 09, 2024	SELL	$42.03 - $53.55 $16,812 - $21,420	-400 Reduced 0.25%	159,380 $6.91 Million
Q4 2023 Feb 12, 2024	SELL	$43.39 - $51.63 $84,610 - $100,678	-1,950 Reduced 1.21%	159,780 $8.08 Million
Q3 2023 Nov 09, 2023	SELL	$38.5 - $47.13 $28,875 - $35,347	-750 Reduced 0.46%	161,730 $7.34 Million
Q1 2023 May 10, 2023	BUY	$33.58 - $41.2 $30,591 - $37,533	911 Added 0.56%	162,480 $5.81 Million
Q4 2022 Feb 09, 2023	SELL	$37.12 - $46.52 $30,623 - $38,379	-825 Reduced 0.51%	161,569 $6.1 Million
Q3 2022 Nov 10, 2022	SELL	$36.54 - $48.66 $7,709 - $10,267	-211 Reduced 0.13%	162,394 $7.18 Million
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $155,379 - $210,700	-4,900 Reduced 2.93%	162,605 $6.02 Million
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $86,652 - $107,416	-2,900 Reduced 1.7%	167,505 $6.2 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $48,018 - $65,812	1,875 Added 1.11%	170,405 $5.19 Million
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $123,091 - $148,818	-3,670 Reduced 2.13%	168,530 $5.65 Million
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $2.53 Million - $3.46 Million	-73,292 Reduced 29.86%	172,200 $6.87 Million
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $1.08 Million - $1.62 Million	-25,405 Reduced 9.38%	245,492 $11 Million
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $223,555 - $297,432	-4,935 Reduced 1.79%	270,897 $15.3 Million
Q3 2020 Nov 16, 2020	SELL	$47.45 - $62.95 $141,401 - $187,591	-2,980 Reduced 1.07%	275,832 $13.1 Million
Q2 2020 Aug 12, 2020	SELL	$46.85 - $61.05 $273,135 - $355,921	-5,830 Reduced 2.05%	278,812 $16.4 Million
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $4.87 Million - $7.43 Million	-117,155 Reduced 29.16%	284,642 $13.5 Million
Q4 2019 Jan 14, 2020	SELL	$53.85 - $65.27 $404,413 - $490,177	-7,510 Reduced 1.83%	401,797 $24.3 Million
Q3 2019 Oct 31, 2019	SELL	$59.06 - $72.15 $2.19 Million - $2.67 Million	-37,008 Reduced 8.29%	409,307 $24.5 Million
Q2 2019 Jul 31, 2019	SELL	$62.09 - $86.14 $278,101 - $385,821	-4,479 Reduced 0.99%	446,315 $28.7 Million
Q1 2019 Apr 30, 2019	SELL	$52.92 - $81.17 $4.55 Million - $6.98 Million	-86,029 Reduced 16.03%	450,794 $36.6 Million
Q4 2018 Feb 08, 2019	SELL	$43.37 - $59.54 $2.2 Million - $3.03 Million	-50,839 Reduced 8.65%	536,823 $29 Million
Q3 2018 Nov 13, 2018	SELL	$42.88 - $53.7 $102,354 - $128,181	-2,387 Reduced 0.4%	587,662 $30.3 Million
Q2 2018 Aug 13, 2018	SELL	$40.53 - $50.7 $72,305 - $90,448	-1,784 Reduced 0.3%	590,049 $24.6 Million
Q1 2018 May 14, 2018	SELL	$44.08 - $55.05 $11 Million - $13.8 Million	-249,891 Reduced 29.69%	591,833 $26.1 Million
Q4 2017 Feb 13, 2018	BUY	$50.3 - $64.39 $6.86 Million - $8.78 Million	136,317 Added 19.32%	841,724 $42.3 Million
Q3 2017 Oct 30, 2017	BUY	$45.56 - $59.57 $32.1 Million - $42 Million	705,407	705,407 $35.8 Million

Others Institutions Holding IONS

# of Institutions

394

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.8B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.

Account

Tocqueville Asset Management L.P. Ionis Pharmaceuticals Inc Transaction History